Trodelvy Scores A Breast Cancer Survival Win For Gilead
Gilead staked money on Trodelvy providing a life-extension benefit when it failed to show promise in halting tumour development in HR-positive HER2-negative breast cancer....
Study Identifies And Closes Gaps In Some High-Risk Cancers
A team of researchers led by C. Patrick Reynolds, M.D., Ph.D., director of the Texas Tech University Health Sciences Center (TTUHSC) School of Medicine...
HIV And COVID-19 Vaccines Could Benefit From Nasal Release
A team led by an assistant professor from the University of Minnesota in the US has created a new method to successfully administer vaccines through...
Enhertu of Daiichi Sankyo, AZ Gains HER2-Mutant Lung Cancer
With two significant FDA clearances in as many weeks, Enhertu from AstraZeneca and Daiichi Sankyo is blazing.
On August 11th, the medication obtained rapid approval...
Pfizer Provides Facts To Back Up Prevnar 20 Authorization
Although Pfizer beat Merck to sell its next-generation pneumococcal vaccination, it lost a more important battle in June when the FDA said its competitor...
ViiV Sets Up A $500,000 Monkeypox Fund As Emergency Response
In a press statement, ViiV Healthcare stated that the Monkeypox Emergency Response Fund would be distributed to U.S. community-based organisations.
ViiV, which has a strong...
Hanmi Reintroduces Liver Drug After Raising Bioavailability
After leveraging its microemulsion technology to increase the absorption rate and so address a shortcoming of the original formulation, Hanmi Pharmaceutical has reintroduced its...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...